Peter Ljubenkov, Md

This early-stage study is testing the safety and side effects of an oral medication called verdiperstat in people with semantic variant primary progressive aphasia (svPPA), a rare form of dementia that causes progressive loss of language and word meaning. About 64 participants wi…